Posts Categorized: MS News

Invitation: Multiple Sclerosis Patient Survey   Opinion Health, an independent research agency based in London, is currently inviting people diagnosed with multiple sclerosis to take part in an online survey. This survey is designed to provide a better understanding of your experience of the treatment you are receiving as well as your treatment preferences.  … Read more »

Interesting article on the benefits of exercise for people with MS.  Read article here. 

Source MS Trust ECTRIMS (European Committee for Treatment and Research In Multiple Sclerosis) hosts the world’s largest conference devoted to basic and clinical research in MS. This year’s meeting took place in Barcelona from 7-10 October and featured a wide range of presentations, posters and reports of new and on-going research.  Read on.

Source Market Watch Biogen Inc. said Wednesday that a late-stage trial of a drug to treat of secondary progressive multiple sclerosis was unsuccessful. The trial of Natalizumab found that the drug was “well-tolerated” by patients but did not meet its primary and secondary endpoints. “While we’re disappointed with these results, we believe this research will… Read more »

Dr. Daniel Kantor talks about the MD1003 Trial analysis on Biotin for Secondary and Primary Progressive Multiple Sclerosis.  Watch here.  

Source MS Trust ECTRIMS is the European Committe for Treatment and Research in Multiple Sclerosis. Every year they hold the world’s largest conference on MS research and this year’s event is taking place this week in Barcelona. Amy Bowen, our Director of Service Development, reports on what is widely expected to be the most significant… Read more »

Source MS Society A new international report on early treatment has been launched today. Brain health: time matters in multiple sclerosis, was written by a global expert group led by UK neurologist Professor Gavin Giovannoni. This follows the MS Society’s consensus paper on early treatment released on Wednesday 30 September.  Read on. 

Source MS Trust: As well as the symptoms caused by ‘flu’, the fever associated with the infection can lead to a worsening of multiple sclerosis symptoms for those people with MS who are adversely affected by heat. NICE guidelines state that people with MS should be offered immunisation against influenza as infections may be associated… Read more »

We love the new MS Trust website – feel free to give them some feedback on their new design.  https://www.mstrust.org.uk

Genentech have announced positive results from a phase III study of ocrelizumab in primary progressive MS Source Pharmiweb.com Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive results from a pivotal Phase III study that evaluated the investigational medicine ocrelizumab in people with primary progressive multiple sclerosis (PPMS).  Read… Read more »